Scarborough, ME (PRWEB) May 15, 2013
Atlantic Peptides LLC, a leader in custom synthetic peptide chemistry service announced today the collaboration with a United Kingdom company to offer cGMP peptides and API. The facility houses over 10,000 sq ft which incorporates eight cGMP suites. This will allow current and future customers in their research and in-process projects from pre-clinical toxicology studies through the early stage clinical trials.
The facility houses over 10,000 square feet of modern laboratories which incorporates eight cGMP suites. The facility has been designed and built to meet national and international standards (EC guidance for GMP, Eudralex Vol. 4, Part I, II and Annex 1; ICH Q7A; US Federal Standard 209 E; and the ISO classification) required for API manufacture.
With the increasing focus on peptide therapeutic agents for healthcare, we aim to offer a complete solution to the pharmaceutical industry, by supplying peptides for pre-GMP research studies through to cGMP grade peptides.
About Atlantic Peptides
Atlantic Peptides scientific is a trusted provider of high quality peptide based products to pharmaceutical and biotechnology companies and academic researchers. Atlantic Peptides offers catalog peptides, custom peptide synthesis, peptide arrays and libraries, cGMP manufacturing of peptide APIs and Generics and is a world leader in complex peptide modification services. Atlantic Peptides provides FFS and FTE services as well as process development and validation, stability studies, regulatory support and documentation. For more information please visit us at http://www.atlanticpeptides.com
Read the full story at http://www.prweb.com/releases/cgmp/atlantic_peptides/prweb10713752.htm.
Copyright©2012 Vocus, Inc.
All rights reserved